A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study (Q34341870)

1 August 2017

title

A blood-based predictor for neocortical Aβ burden in Alzheimer's disease: results from the AIBL study (English)

1 reference

Alzheimer's Disease Neuroimaging Initiative

1 August 2017

0 references

20

object named as

Alzheimer’s Disease Neuroimaging Initiative

1 reference

1 August 2017

W Wilson

3

0 references

Gareth R. Jones

object named as

G Jones

11

0 references

Richard Head

object named as

R Head

10

0 references

author name string

S C Burnham

1

1 reference

1 August 2017

N G Faux

2

1 reference

1 August 2017

S M Laws

4

1 reference

1 August 2017

D Ames

5

1 reference

1 August 2017

J Bedo

6

1 reference

1 August 2017

A I Bush

7

1 reference

1 August 2017

J D Doecke

8

1 reference

1 August 2017

K A Ellis

9

1 reference

1 August 2017

H Kiiveri

12

1 reference

1 August 2017

R N Martins

13

1 reference

1 August 2017

A Rembach

14

1 reference

1 August 2017

C C Rowe

15

1 reference

1 August 2017

O Salvado

16

1 reference

1 August 2017

S L Macaulay

17

1 reference

1 August 2017

C L Masters

18

1 reference

1 August 2017

V L Villemagne

19

1 reference

1 August 2017

Australian Imaging, Biomarkers and Lifestyle Study Research Group

21

1 reference

1 August 2017

language of work or name

English

0 references

publication date

30 April 2013

1 reference

1 August 2017

1 reference

1 August 2017

volume

19

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

519-526

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Mild cognitive impairment: clinical characterization and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Amyloid beta protein 1-40 and 1-42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Plasma apolipoprotein E and Alzheimer disease risk: the AIBL study of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Multiple imputation by chained equations: what is it and how does it work?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject Brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Biological markers for therapeutic trials in Alzheimer's disease. Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Frequent amyloid deposition without significant cognitive impairment among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

ApoE-4 and age at onset of Alzheimer's disease: the NIMH genetics initiative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Blood-based protein biomarkers for diagnosis of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

A role for pancreatic polypeptide in the regulation of gastric emptying and short-term metabolic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Minireview: Gut peptides regulating satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Plasma ß-amyloid and cognitive decline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

A serum protein-based algorithm for the detection of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Revising the definition of Alzheimer's disease: a new lexicon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Quits and job changes among home care workers in Maine: the role of wages, hours, and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

Human pancreatic polypeptide has a marked diurnal rhythm that is affected by ageing and is associated with the gastric TFF2 circadian rhythm

21 January 2018

1 reference

12 December 2020

Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease

1 reference

12 December 2020

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease

1 reference

12 December 2020

Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI

1 reference

12 December 2020

Elevated levels of circulating pancreatic polypeptide in inflammatory and infectious disorders

1 reference

12 December 2020

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

1 reference

12 December 2020

Amyloid-β peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients.

1 reference

12 December 2020

Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease

1 reference

12 December 2020

Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1038%2FMP.2013.40

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/MP.2013.40

1 reference

1 August 2017

1 reference